𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: An international study using the nonmotor symptoms questionnaire

✍ Scribed by K. Ray Chaudhuri; Cristina Prieto-Jurcynska; Yogini Naidu; Tanya Mitra; Belen Frades-Payo; Susanne Tluk; Anne Ruessmann; Per Odin; Graeme Macphee; Fabrizio Stocchi; William Ondo; Kapil Sethi; Anthony H.V. Schapira; Juan Carlos Martinez Castrillo; Pablo Martinez-Martin


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
65 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The nonmotor symptoms (NMS) of Parkinson's disease (PD) are less well recognised and can be more troublesome to patients and carers than classical motor features. NMS are frequently missed during routine consultations and such under‐recognition may have implications on quality of care given that many NMS are treatable. To determine the proportion of patients not declaring NMS to healthcare professional (HCP) as assessed by self completion of the NMS questionnaire (NMSQuest), a validated, self‐completing questionnaire with 30 items. Multicentre international study. The data was collected from PD patients across all age groups and stages attending outpatient clinics in specialist and care of the elderly settings. 242 patients recruited and undeclared NMS ranged from 31.8% (diplopia) to 65.2% (delusions). The most frequently nondeclared symptoms were delusions, daytime sleepiness, intense and vivid dreams, and dizziness. In many, appropriate treatments for undeclared NMS were started only after these were recognised following completion of NMSQuest. NMS of PD are frequently undeclared at routine hospital consultation and may be related to the fact that patients often do not link these symptoms with PD or may be too embarrassed to discuss these. Use of NMSQuest allows patients to flag symptoms which may be otherwise undeclared and remain untreated when potential treatments exist. Β© 2010 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Prevalence of nonmotor symptoms in Parki
✍ Pablo Martinez-Martin; Anthony H.V. Schapira; Fabrizio Stocchi; Kapil Sethi; Per πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 204 KB πŸ‘ 1 views

## Abstract 2006, there was, no single instrument (questionnaire or scale) for attempting a comprehensive assessment of the wide range of nonmotor symptoms (NMS) of Parkinson's disease (PD). The PD nonmotor group, a multidisciplinary group of experts including patient group representatives develope

The nonmotor symptoms of Parkinson's dis
✍ Shen-Yang Lim; Anthony E. Lang πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 140 KB πŸ‘ 1 views

## Abstract Nonmotor symptoms (NMS) are very common in Parkinson's disease (PD) and may result in significant disability. The increased focus on these important clinical features represents a major advance in the care of PD patients. In this article, we provide an overview of recent developments in

International multicenter pilot study of
✍ Kallol Ray Chaudhuri; Pablo Martinez-Martin; Anthony H.V. Schapira; Fabrizio Sto πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 314 KB

## Abstract Nonmotor symptoms (NMS) of Parkinson's disease (PD) are not well recognized in clinical practice, either in primary or in secondary care, and are frequently missed during routine consultations. There is no single instrument (questionnaire or scale) that enables a comprehensive assessmen

The metric properties of a novel non-mot
✍ Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G. Brown; Kapil Sethi; Fabr πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views

## Abstract Non‐motor symptoms (NMS) in Parkinson's disease (PD) are common, significantly reduce quality of life and at present there is no validated clinical tool to assess the progress or potential response to treatment of NMS. A new 30‐item scale for the assessment of NMS in PD (NMSS) was devel